First Line Comparative Study of EN3348 (MCC) vs BCG in NMIBC
- Status
- WITHDRAWN
- Phase
- PHASE3
Clinical Trials Related to Bladder Cancer
Related studies linked through entity extraction aliases.
Effects of Noradrenaline Administration Combined With Restrictive Intraoperative Fluid Substitution on Perioperative Outcome in Patients Undergoing Radical Cystectomy
- Status
- COMPLETED
- Phase
- NA
Neobladder Posterior Wall Suspended With Round Ligament of Uterus
- Status
- COMPLETED
- Phase
- NA
RAD001 and Intravesical Gemcitabine in BCG-Refractory Primary or Secondary Carcinoma In Situ of the Bladder
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bladder Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Cancer in Patients With Gabapentin (GPRD)
- Status
- COMPLETED
- Phase
- N/A
S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer
- Status
- COMPLETED
- Phase
- NA
Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the Bladder
- Status
- UNKNOWN
- Phase
- PHASE2
Sorafenib in Urothelium Cancer of Bladder
- Status
- TERMINATED
- Phase
- PHASE2
Eingeschränkte vs Ausgedehnte Lymphadenektomie LEA
- Status
- COMPLETED
- Phase
- NA
Tumorspecific T-cell Immunity in Bladder Cancer as Prognostic Marker
- Status
- UNKNOWN
- Phase
- N/A
Standard Surgery or Minimal-Access Surgery in Treating Patients With Bladder Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Comparison Study of Narrow Band Imaging Versus White Light Resection in Patients With Bladder Tumors/Cancer
- Status
- COMPLETED
- Phase
- NA
Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer
- Status
- COMPLETED
- Phase
- NA
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
- Status
- COMPLETED
- Phase
- N/A
1B Intravesical Administration of SCH 721015 (Ad-IFNa) in Admixture With SCH 209702 (Syn3) for The Treatment of BCG Refractory Superficial Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Feasibility of Online Adaptive Radiotherapy for Muscle Invasive Bladder Cancer
- Status
- COMPLETED
- Phase
- NA
Eribulin Mesylate Administered in Combination With Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Cisplatin Alone as First-Line Therapy for Locally Advanced or Metastatic Bladder Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2